Trademark Overview
On Monday, March 23, 2026, a trademark application was filed for LARPYCSI with the United States Patent and Trademark Office. The USPTO has given the LARPYCSI trademark a serial number of 99719337. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, March 23, 2026. This trademark is owned by AstraZeneca AB. The LARPYCSI trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, dermatological, neurological, gastrointestinal and immune systems; Pharmaceutical preparations for the treatment of infection, inflammation, hematological, and autoimmune related diseases and disorders; Pharmaceutical preparations for use in oncology; Vaccines; Antibodies for medical purposes